Stockreport

LifeMD Q1 2021 Revenues on Track to Exceed $17 Million, up 295%, with Subscriptions Representing More than 80% of Total Revenue

LifeMD, Inc.  (LFMD) 
PDF NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD) (formerly Conversion Labs), a leading direct-to-patient telehealth company, expects revenue fo [Read more]